Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death

被引:193
作者
Donovan, M [1 ]
Cotter, TG [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Cell Dev & Dis Biochem Dept, Cork, Ireland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2004年 / 1644卷 / 2-3期
关键词
Bcl-2; family; mitochondrion; apoptosis; caspase-independent; AIF;
D O I
10.1016/j.bbamcr.2003.08.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Programmed cell death (PCD) is essential for normal development and maintenance of tissue homeostasis in multicellular organisms. While it is now evident that PCD can take many different forms, apoptosis is probably the most well-defined cell death programme. The characteristic morphological and biochemical features associated with this highly regulated form of cell death have until recently been exclusively attributed to the caspase family of cysteine proteases. As a result, many investigators affiliate apoptosis with its pivotal execution system, i.e. caspase activation. However, it is becoming increasingly clear that PCD or apoptosis can also proceed in a caspase-independent manner and maintain key characteristics of apoptosis. Mitochondrial integrity is central to both caspase-dependent and-independent cell death. The release of pro-apoptotic factors from the mitochondrial intermembrane space is a key event in a cell's commitment to die and is under the tight regulation of the Bcl-2 family. However, the underlying mechanisms governing the efflux of these pro-death molecules are largely unknown. This review will focus on the regulation of mitochondrial integrity by Bcl-2 family members with particular attention to the controlled release of factors involved in caspase-independent cell death. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:133 / 147
页数:15
相关论文
共 152 条
[141]   Activation of CPP32-like proteases is not sufficient to trigger apoptosis: Inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity [J].
Wright, SC ;
Schellenberger, U ;
Wang, H ;
Kinder, DH ;
Talhouk, JW ;
Larrick, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1107-1117
[142]   Presence of DNA fragmentation and lack of neuroprotective effect in DFP45 knockout mice subjected to traumatic brain injury [J].
Yakovlev, AG ;
Di, X ;
Movsesyan, V ;
Mullins, PGM ;
Wang, GP ;
Boulares, H ;
Zhang, JH ;
Xu, M ;
Faden, AI .
MOLECULAR MEDICINE, 2001, 7 (03) :205-216
[143]  
Yamaguchi H, 2003, CANCER RES, V63, P1483
[144]   DNA binding is required for the apoptogenic action of apoptosis inducing factor [J].
Ye, H ;
Cande, C ;
Stephanou, NC ;
Jiang, SL ;
Gurbuxani, S ;
Larochette, N ;
Daugas, E ;
Garrido, C ;
Kroemer, G ;
Wu, H .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (09) :680-684
[145]   Inhibition of Bid-induced apoptosis by Bcl-2 - tBid insertion, Bax translocation, and Bax/Bak oligomerization suppressed [J].
Yi, XL ;
Yin, XM ;
Dong, Z .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) :16992-16999
[146]   Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis [J].
Yin, XM ;
Wang, K ;
Gross, A ;
Zhao, YG ;
Zinkel, S ;
Klocke, B ;
Roth, KA ;
Korsmeyer, SJ .
NATURE, 1999, 400 (6747) :886-891
[147]   Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor [J].
Yu, SW ;
Wang, HM ;
Poitras, MF ;
Coombs, C ;
Bowers, WJ ;
Federoff, HJ ;
Poirier, GG ;
Dawson, TM ;
Dawson, VL .
SCIENCE, 2002, 297 (5579) :259-263
[148]   THE C-ELEGANS CELL-DEATH GENE CED-3 ENCODES A PROTEIN SIMILAR TO MAMMALIAN INTERLEUKIN-1-BETA-CONVERTING ENZYME [J].
YUAN, JY ;
SHAHAM, S ;
LEDOUX, S ;
ELLIS, HM ;
HORVITZ, HR .
CELL, 1993, 75 (04) :641-652
[149]   The mitochondrion in apoptosis: how Pandora's box opens [J].
Zamzami, N ;
Kroemer, G .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (01) :67-71
[150]   Bid acts on the permeability transition pore complex to induce apoptosis [J].
Zamzami, N ;
El Hamel, C ;
Maisse, C ;
Brenner, C ;
Muñoz-Pinedo, C ;
Belzacq, AS ;
Costantini, P ;
Vieira, H ;
Loeffler, M ;
Molle, G ;
Kroemer, G .
ONCOGENE, 2000, 19 (54) :6342-6350